Peer-reviewedCC BY-NC-NDTranslational andrology and urology
The PROSA and cons of prostate cancer screening.
- 1Department of Radiology, Massachusetts General Hospital, Mass General Brigham, Boston, MA, USA.
- 2Harvard Medical School, Boston, MA, USA.
Related
- Prostate-specific antigen (PSA) test for prostate cancer screening
- 4Kscore as a Pre-MRI Reflex Test for Men with PSA 1.80–2.99 ng/ml in the Göteborg-2 Prostate Cancer Screening Trial
- The Pros & Cons of Measuring Plasma Ammonia in the Management of Patients With Cirrhosis: An ISHEN Debate
- Case Report: Prostatic infarction mimicking prostate cancer in a patient with markedly elevated prostate-specific antigen
- Cancer‐Related Fever in Metastatic Prostate Cancer: A Case Report
BibTeX
@article{cochran2026prosa,
title = {{The PROSA and cons of prostate cancer screening.}},
author = {Rory L Cochran and Mukesh G Harisinghani},
journal = {Translational andrology and urology},
year = {2026},
month = oct,
doi = {10.21037/tau-2026-0791},
url = {https://europepmc.org/article/MED/42997103},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - The PROSA and cons of prostate cancer screening.
AU - Rory L Cochran
AU - Mukesh G Harisinghani
PY - 2026
DA - 2026/10/22
JO - Translational andrology and urology
DO - 10.21037/tau-2026-0791
UR - https://europepmc.org/article/MED/42997103
SN - 2223-4691
ER -